A Multi-center Study of Spherule-Derived Coccidioidin

Completed · Phase 3

Conditions studied: Coccidioidomycosis

In brief

Adult volunteers were skin tested with 1.27 ug spherule-derived coccidioidin. The skin test antigen was evaluated in three different populations of adult volunteers to determine the safety and efficacy of the product in the assessment of delayed-type hypersensitivity to Coccidioides immitis. Induration greater than or equal to 5 mm after 48 hours was considered positive for exposure to C. immitis.

Key facts

Study ID
NCT00690092
Run by
Nielsen BioSciences, Inc.
People needed
113
Starts
2005-05-01
Expected to finish
2007-09-01
Last updated by the study team
2013-10-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.